| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
034
|
Date of Entry 01/30/2014
|
|
FR Recognition Number
|
14-336
|
| Standard | |
ISO 14161 Second edition 2009-09-15 Sterilization of health care products - Biological indicators - Guidance for the selection, use and interpretation of results |
|
Identical AdoptionANSI AAMI ISO 14161-2009/(R)2014 Sterilization of health care products - Biological indicators: Guidance for the selection, use and interpretation of results |
|
Scope/AbstractISO 14161:2009 provides guidance for the selection, use and interpretation of results from application of biological indicators when used in the development, validation and routine monitoring of sterilization processes.
ISO 14161:2009 applies to biological indicators for which International Standards exist.
|
|
| Extent of Recognition
|
Rationale for Recognition
| This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
| FDA recognition of ISO 14161 Second edition 2009-09-15 [Rec# 14-336] will be superseded by recognition of ISO 11138-7 First edition 2019-03 [Rec# 14-610]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 14-336] until July 4, 2027. After this transition period, declarations of conformity to [Rec# 14-336] will not be accepted. |
|
Public Law, CFR Citation(s) and Procode(s)*
| Regulation Number |
Device Name |
Device Class |
Product Code |
| §880.2800 |
Indicator, Biological Sterilization Process
|
Class 2
|
FRC
|
| 880.2805 |
Biological Sterilization Process Indicator With Recombinant-Dna Plasmid
|
Class 2
|
OWP
|
|
Relevant FDA Guidance and/or Supportive Publications*
Biological Indicator (BI) Premarket Notification [510(k)] Submissions: Guidance for Industry and FDA Staff, Issued October 2007.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contacts
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |